# Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease

> **NCT05122598** · PHASE2 · UNKNOWN · sponsor: **Evon Medics LLC** · enrollment: 200 (estimated)

## Conditions studied

- Mild Cognitive Impairment
- Early Alzheimer's Disease
- Memory Impairment

## Interventions

- **DRUG:** COT
- **DRUG:** Sham

## Key facts

- **NCT ID:** NCT05122598
- **Lead sponsor:** Evon Medics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-15
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-04-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-05-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05122598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05122598, "Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05122598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*